Clintec Announces Further Expansion of it’s Partnership with Medidata. 

in Pharmaceutical News

Clintec International, an award winning, global Clinical Research Organisation (CRO), enhances its data management capabilities to include Medidata’s (NASDAQ: MDSO) latest generation of RAVE EDC (electronic data capture) to ensure superior operational efficiency and advanced functionality.

Clintec is pleased to announce further expansion of it’s partnership with Medidata.  Clintec received accreditation in RAVE EDC, upgrading its suite of offerings on the Medidata Clinical Cloud® platform. As a Medidata Partner, Clintec has implemented the industry-leading electronic data capture, management and reporting solution  (Rave EDC), the coding solution (Rave Coder), and Medidata’s clinical trial management (Edge CTMS) platforms.

Clintec’s newest advancement, Medidata’s latest Rave EDC, makes it’s processes more agile and scalable allowing it to offer customised and flexible solutions to it’s clients. “Medidata RAVE EDC will enable us to provide our clients with the state-of-the-art capabilities that they require. It further enhances our clinical research efficiencies—accelerating study timelines, reducing development costs, while providing the highest quality.”

We’re excited to use this cutting-edge technology solution on Medidata’s industry-leading, unified cloud platform to manage clinical trials across all therapeutic areas and therefore elevate our client services –Dr. Buttar, Clintec International chief executive officer

“We’re thrilled that Clintec is further expanding its use of our unified platform to include the latest generation of Rave EDC,” said Glen de Vries, Medidata president and co-founder. “This marks an important milestone in providing their clients with the full breadth of Rave solutions to improve the quality and the efficiency of global studies.”

About Clintec International

Clintec International is a global mid-market full-service Contract Research Organization (CRO) founded in Europe in 1997, which has organically grown its presence into over 50 developed and emerging countries. Clintec is positioned as one of the most geographically diverse mid-market CROs, with deep expertise in advanced functional outsourcing models for clinical research. Clintec provides innovative full-service and functional outsourcing clinical research solutions to 7 of the top 10 pharmaceutical companies in the world, as well as speciality biotechnology and medical device firms in oncology, rare diseases and other therapeutic areas. In addition, Clintec has a strong agenda for social responsibility, diversity and inclusion, by providing clinical research solutions in diverse geographic locations inclusive of Sub-Saharan African countries, aligning with not-for-profit organizations, to develop medicines for infectious diseases in countries where significant unmet needs exist.

Headquartered in the UK and now in its 21st year of significant global expansion, Clintec’s focused, flexible and forward-looking approach ensures quick and reliable results customized to the global clinical research needs of its clients.

About Medidata

Medidata is reinventing global drug and medical device development by creating the industry’s leading cloud-based solutions for clinical research. Through advanced applications and intelligent data analytics, Medidata helps advance the scientific goals of life sciences customers worldwide, including over 850 global pharmaceutical companies, biotech, diagnostic and device firms, leading academic medical centres, and contract research organizations.

Leave a Reply

Your email address will not be published.


Latest from Pharmaceutical News

Go to Top